Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation

Meta-Analysis Comparing Cryoballoon Versus Radiofrequency as First Ablation Procedure for Atrial Fibrillation

(2020) Federico Fortuni et al.   AMERICAN JOURNAL OF CARDIOLOGY

Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation

(2020) Derek S. Chew et al.   Circulation-Arrhythmia and Electrophysiology

Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial

(2020) Jeanne E. Poole et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

(2020) Paulus Kirchhof et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

(2019) Douglas L. Packer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Atrial fibrillation ablation in practice: assessing CABANA generalizability

(2019) Peter A Noseworthy et al.   EUROPEAN HEART JOURNAL

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure

(2018) Mohit K. Turagam et al.   ANNALS OF INTERNAL MEDICINE

Radiofrequency Ablation of Persistent Atrial Fibrillation

(2016) Ayman A. Hussein et al.   Circulation-Arrhythmia and Electrophysiology

Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis

(2015) A. Hakalahti et al.   EUROPACE

Catheter Ablation and Antiarrhythmic Drug Therapy as First- or Second-Line Therapy in the Management of Atrial Fibrillation

(2014) Abdur Rahman Khan et al.   Circulation-Arrhythmia and Electrophysiology

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

(2014) Carlos A. Morillo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010

(2013) Abhishek Deshmukh et al.   CIRCULATION

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke

(2013) J. P. Piccini et al.   EUROPEAN HEART JOURNAL

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation

(2013) Douglas L. Packer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

(2012) Paulus Kirchhof et al.   LANCET

Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation

(2012) Jens Cosedis Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

(2010) David J. Wilber et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis

(2009) James F. Doyle et al.   MAYO CLINIC PROCEEDINGS